Prognostic Significance and Measurement of Exercise-Derived Hemodynamic Variables in Patients With Heart Failure

doi:10.1016/j.cardfail.2007.05.004

Journal of Cardiac Failure

Volume 13, Issue 8, October 2007, Pages 672-679

https://doi.org/10.1016/j.cardfail.2007.05.004 Get rights and content

Abstract

The peak VO₂ is an important prognostic measurement in the evaluation of patients with heart failure and is used to monitor the progress of the condition, especially in selecting patients for cardiac transplantation. However, peak VO₂ may be influenced by noncardiac factors such as age, sex, motivation, anemia, and muscle deconditioning. These confounding factors may diminish somewhat the prognostic power of peak VO₂. Several groups have looked at exercise-derived variables beyond peak VO₂ to assess whether a more direct assessment of cardiac function, using exercise-derived hemodynamic variables, may yield more precise prognostic information than standard cardiopulmonary-derived data. This article reviews the evidence that cardiac work related to exercise may enhance the prognostic value of peak VO₂ in the evaluation of patients with heart failure and briefly discusses the available methods for measuring these parameters.

Section snippets

Confounding Factors of Peak VO₂

The use of a specific peak exercise VO₂ level as a selection criterion for heart transplantation may have several potential confounding factors. In CHF, patients' peak exercise VO₂ can be influenced by comorbidities and noncardiac factors, such as muscle deconditioning, motivation, anemia, abnormal reflex response, and obesity.⁷ Therefore, peak VO₂ is affected not only by the cardiac response to exercise as observed in healthy subjects but also by limited skeletal muscle mass and perfusion in

Potential Prognostic Value of Ancillary Data During Cardiopulmonary Testing

Several groups have looked at exercise-derived variables other than peak VO₂ as predictors of outcomes, such as blood pressure response to exercise,¹¹ the slope of the ratio of minute ventilation to carbon dioxide production (VE/VCO₂), or its value at the anaerobic threshold¹² and oxygen kinetics in the post-exercise recovery phase.¹³ It should be noted that these parameters, unlike VO₂, are not influenced by the mechanical work done during exercise testing but reflect alterations in the

Potential Arguments for Measuring the Hemodynamic Response to Exercise

It is generally thought that the reason for peak VO₂ to be such an important prognostic factor is that it is an indirect measure for CO and thus provides an index of cardiac reserve of the patients with CHF. However, as mentioned earlier, it was argued by Mancini and LeJemtel⁸ that the usefulness of peak VO₂ to predict prognosis might also be because it reflects the derangements that the failing heart causes in the periphery. However, because peak VO₂ is only an indirect measure of CO, there

Evidence of the Prognostic Value of Assessing the Hemodynamic Response to Exercise in Patients With Heart Failure

In 1986, Tan²⁷ published a study on 63 patients with severe heart failure. A series of hemodynamic parameters (cardiac index, stroke work index, pulmonary artery wedge pressure, and cardiac power output [CPO]) were measured at rest and under maximum stimulation with dobutamine using the thermodilution technique. The CPO was defined as the product of CO and the mean blood pressure. The patients were followed for 1 year after the initial test, during which time 23 of them died. Parameters

Methods for Measuring Cardiac Output

Methods of measuring CO, especially at peak exercise, are not straightforward. Invasively derived hemodynamic measurements during exercise raise serious concerns regarding risks and complexity of testing. Insertion of a catheter into the pulmonary artery may be associated with complications (eg, pneumothorax, local pain, vasovagal reactions, atrioventricular blocks, and arrhythmias). During exercise, patients are tethered to the Swan-Ganz catheter, restricting movement and occasionally causing

Conclusions

Over the years, there have been many indicators found to be predictive of prognosis in CHF. They can broadly be divided into those that are surrogates of outcomes of CHF and those that are direct indicators of cardiac dysfunction. The former category includes serum urea and plasma brain natriuretic peptide. The variables belonging to the latter category are those in which improvement may lead directly to an improvement of the condition. Because the cardiac work related to exercise (eg, CO and

References (56)

J. Szlachcic et al.
Correlates and prognostic implication of exercise capacity in chronic congestive heart failure
Am J Cardiol
(1985)
J.R. Wilson et al.
Dissociation between peak exercise oxygen consumption and hemodynamic dysfunction in potential heart transplant candidates
J Am Coll Cardiol
(1995)
N. Osada et al.
Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise considered for heart transplantation
J Am Coll Cardiol
(1998)
A.M. Stelken et al.
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
J Am Coll Cardiol
(1996)
L.H. Lund et al.
Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy
Am J Cardiol
(2003)
L.B. Tan
Cardiac pumping capability and prognosis in heart failure
Lancet
(1986)
B.P. Griffin et al.
Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy
Am J Cardiol
(1991)
M. Metra et al.
Use of cardiopulmonary exercise testing with hemodynamic monitoring in the prognostic assessment of ambulatory patients with chronic heart failure
J Am Coll Cardiol
(1999)
D.D. Mendoza et al.
Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac diseases
Am Heart J
(2007)
R. Fincke et al.
For the SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry
J Am Coll Cardiol
(2004)

C. Scharf et al.

Noninvasive assessment of cardiac pumping capacity during exercise predicts prognosis in patients with congestive heart failure

Chest

(2002)

S.G. Williams et al.

Comparison and relation of indirect and direct dynamic indexes of cardiac pumping capacity in chronic heart failure

Am J Cardiol

(2005)

M. Packer et al.

For the PREDICT Investigators. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure

J Am Coll Cardiol

(2006)

R. Belardinelli et al.

Comparison of impedance cardiography with thermodilution and direct Fick methods for non-invasive measurements of stroke volume and cardiac output during incremental exercise in patients with ischemic cardiomyopathy

Am J Cardiol

(1996)

P. Agostoni et al.

Non-invasive measurement of cardiac output during exercise by inert gas rebreathing technique: a new tool for heart failure evaluation

J Am Coll Cardiol

(2005)

C. Lang et al.

Ease of non-invasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure

Am J Cardiol

(2007)

L.E. Bennet et al.

Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT international registry for thoracic organ transplantation

Clin Transpl

(2001)

N.M. Edwards et al.

Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University

Clin Transpl

(1999)

L.W. Stevenson et al.

The impending crisis awaiting cardiac transplantation: modeling a solution based on selection

Circulation

(1994)

M.R. Costanzo et al.

Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association

Circulation

(1995)

D.M. Mancini et al.

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

Circulation

(1991)

D. Mancini et al.

Is ventilatory classification preferable to peak oxygen consumption for risk stratification in heart failure?

Circulation

(2007)

M.R. Becklake et al.

Influence of age and sex on exercise cardiac output

J Appl Physiol

(1965)

L.W. Stevenson et al.

Target heart failure populations for newer therapies

Circulation

(1995)

M. Robbins et al.

Ventilatory and heart rate responses to exercise. Better predictors of mortality then peak oxygen consumption

Circulation

(1999)

A. Cohen-Solal et al.

Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy

Circulation

(1995)

K.D. Aaronson et al.

Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure

J Heart Lung Transplant

(1995)

F. Kleber et al.

Impairment of ventilatory efficiency in heart failure: prognostic impact

Circulation

(2000)

Cited by (63)

Echocardiography in the diagnostic evaluation and phenotyping of heart failure with preserved ejection fraction
2022, Journal of Cardiology
Heart failure with preserved ejection fraction (HFpEF) represents one of the greatest unmet needs in modern cardiology given its diagnostic difficulty and limited therapeutic options. Echocardiography provides valuable information on cardiac structure, function, and hemodynamics and plays a central role in the evaluation of HFpEF. Echocardiography is crucial in identifying HFpEF among patients with dyspnea, especially when overt congestion is absent. The combination of echocardiographic indices of diastolic function, clinical characteristics, and natriuretic peptide tests has been proposed in the diagnostic evaluation of patients with suspected HFpEF. Echocardiography also provides valuable insight into the pathophysiology and underlying phenotypes of HFpEF. Exercise stress echocardiography can also detect abnormalities that develop only during exercise. This may enhance the diagnosis of HFpEF by demonstrating elevation in the left ventricular filling pressure and may have potential for better pathophysiological characterization. This review focuses on the role of echocardiography in the diagnostic evaluation and phenotyping of HFpEF. We also discuss the potential role of exercise stress echocardiography for the diagnosis and disease phenotyping of HFpEF.
Considerations for Heart Failure Care During the COVID-19 Pandemic
2020, JACC: Heart Failure
Citation Excerpt :
In patients with pre-existing biventricular failure, further elevation in pulmonary pressures secondary to ARDS can worsen right ventricular function. Patients with advanced HF, including those with durable LVAD support, have severely reduced functional capacity (30,31), as measured by peak VO2, and impaired ability to augment cardiac output in response to physiological stressors. These factors collectively decrease their cardiopulmonary reserve.
The coronavirus-2019 (COVID-19) infection pandemic has affected the care of patients with heart failure (HF) who have contracted COVID-19 as well as those without COVID-19 who have been impacted by the restructuring of health care delivery. Patients with HF and other cardiovascular comorbidities are at risk for severe disease and complications of infection. Similarly, COVID-19 has been demonstrated to cause myocarditis and may be implicated in new-onset cardiomyopathy. During this pandemic, special considerations are needed for patients with advanced HF, including those supported by durable left ventricular assist devices (LVADs) and heart transplant recipients. The purpose of this review is to summarize emerging data regarding the development of HF secondary to COVID-19 infection in patients with advanced HF and the implications of the pandemic for care of uninfected patients with HF.
The Power of Cardiac Output
2019, Journal of Cardiac Failure
Cardiopulmonary Exercise Testing, Impedance Cardiography, and Reclassification of Risk in Patients Referred for Heart Failure Evaluation: CPX, ICG, and Reclassification of Risk in Heart Failure
2019, Journal of Cardiac Failure
Citation Excerpt :
Although peak VO2 is considered the gold standard noninvasive marker of cardiopulmonary function largely because it is considered an indirect reflection of CO,38 it is also known that peak VO2 can be confounded by numerous factors (including age, gender, obesity, motivation, deconditioning, peripheral neuropathy, and other localized muscle conditions). Thus, peak VO2 does not accurately reflect the CO response to exercise in many patients, and this has given rise to the concept that noninvasive hemodynamic measures may provide important prognostic information.8,9,12–18 Studies are mixed in terms of whether noninvasive estimates of CO during exercise outperform peak VO2 in stratifying risk in patients with HF.13
An impaired cardiac output response to exercise is a hallmark of chronic heart failure (HF). We determined the extent to which impedance cardiography (ICG) during exercise in combination with cardiopulmonary exercise test (CPX) responses reclassified risk for adverse events in patients with HF.
CPX and ICG were performed in 1236 consecutive patients (48±15 years) evaluated for HF. Clinical, ICG and CPX variables were acquired at baseline and subjects were followed for the composite outcome of cardiac-related death, hospitalization for worsening HF, cardiac transplantation, and left ventricular assist device implantation. Cox proportional hazards analyses including clinical, noninvasive hemodynamic, and CPX variables were performed to determine their association with the composite endpoint. Net reclassification improvement (NRI) was calculated to quantify the impact of adding hemodynamic responses to a model including established CPX risk markers on reclassifying risk. There were 422 events. Among CPX variables, peak VO₂ and indices of ventilatory inefficiency (VE/VCO₂ slope, oxygen uptake efficiency slope) were significant predictors of risk for adverse events. Among hemodynamic variables, change in cardiac index, peak cardiac time interval, and peak left cardiac work index were the strongest predictors of risk. Having 5 impaired CPX and ICG responses to exercise yielded a sevenfold higher risk for adverse events compared with having no abnormal responses. Combining ICG responses to CPX resulted in NRIs ranging between 0.34 and 0.89, attributable to better reclassification of events.
Cardiac hemodynamics determined by ICG complement established CPX measures in reclassifying risk among patients with HF.
Diastolic Intra–Left Ventricular Pressure Difference During Exercise: Strong Determinant and Predictor of Exercise Capacity in Patients With Heart Failure
2019, Journal of Cardiac Failure
Although the enhancement of early-diastolic intra–left ventricular pressure difference (IVPD) during exercise is considered to maintain exercise capacity, little is known about their relationship in heart failure (HF).
Cardiopulmonary exercise testing and exercise-stress echocardiography were performed in 50 HF patients (left ventricular [LV] ejection fraction 39 ± 15%). Echocardiographic images were obtained at rest and submaximal and peak exercise. Color M-mode Doppler images of LV inflow were used to determine IVPD. Thirty-five patients had preserved exercise capacity (peak oxygen consumption [VO₂] ≥14 mL·kg⁻¹·min⁻¹; group 1) and 15 patients had reduced exercise capacity (group 2). During exercise, IVPD increased only in group 1 (group 1: 1.9 ± 0.9 mm Hg at rest, 4.1 ± 2.0 mm Hg at submaximum, 4.7 ± 2.1 mm Hg at peak; group 2: 1.9 ± 0.8 mm Hg at rest, 2.1 ± 0.9 mm Hg at submaximum, 2.1 ± 0.9 mm Hg at peak). Submaximal IVPD (r = 0.54) and peak IVPD (r = 0.69) were significantly correlated with peak VO₂. Peak IVPD determined peak VO₂ independently of LV ejection fraction. Moreover, submaximal IVPD could well predict the reduced exercise capacity.
Early-diastolic IVPD during exercise was closely associated with exercise capacity in HF. In addition, submaximal IVPD could be a useful predictor of exercise capacity without peak exercise in HF patients.
Expanding the clinical classification of heart failure: Inclusion of cardiac function during exercise
2018, Lifestyle in Heart Health and Disease
Despite recent advances in the pathophysiological understanding of heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction, there remains an appreciable level of patients whose clinical severity is not optimally classified using traditional paradigms. Although exercise intolerance is a hallmark feature across HF, while also a key marker of patient prognosis that is not related to resting left ventricular ejection fraction, it is not currently routine to objectively assess the functional response of the cardiac system to exercise in the clinical setting. By contrast, accumulating patient-based evidence supports links between impaired exercise cardiac pumping capability and prognosis related to exercise intolerance in HF. Therefore, as a high-priority clinical need, this chapter focuses on discussing the science and real-world clinical value of routinely assessing exercise cardiac pumping capability in HF, which will advance the pathophysiological understanding of exercise intolerance in HF while also strengthening the traditional model used for the clinical classification of HF patients.

View all citing articles on Scopus

: Conflict of Interest Disclosures: None of the authors have a conflict of interest.

View full text

Review ArticlePrognostic Significance and Measurement of Exercise-Derived Hemodynamic Variables in Patients With Heart Failure

Abstract

Section snippets

Confounding Factors of Peak VO2

Potential Prognostic Value of Ancillary Data During Cardiopulmonary Testing

Potential Arguments for Measuring the Hemodynamic Response to Exercise

Evidence of the Prognostic Value of Assessing the Hemodynamic Response to Exercise in Patients With Heart Failure

Methods for Measuring Cardiac Output

Conclusions

Am J Cardiol

J Am Coll Cardiol

J Am Coll Cardiol

J Am Coll Cardiol

Am J Cardiol

Lancet

Am J Cardiol

J Am Coll Cardiol

Am Heart J

J Am Coll Cardiol

Chest

Am J Cardiol

J Am Coll Cardiol

Am J Cardiol

J Am Coll Cardiol

Am J Cardiol

Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT international registry for thoracic organ transplantation

Clin Transpl

Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University

Clin Transpl

The impending crisis awaiting cardiac transplantation: modeling a solution based on selection

Circulation

Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association

Circulation

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

Circulation

Is ventilatory classification preferable to peak oxygen consumption for risk stratification in heart failure?

Circulation

Influence of age and sex on exercise cardiac output

J Appl Physiol

Target heart failure populations for newer therapies

Circulation

Ventilatory and heart rate responses to exercise. Better predictors of mortality then peak oxygen consumption

Circulation

Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy

Circulation

Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure

J Heart Lung Transplant

Impairment of ventilatory efficiency in heart failure: prognostic impact

Circulation

Review Article
Prognostic Significance and Measurement of Exercise-Derived Hemodynamic Variables in Patients With Heart Failure

Confounding Factors of Peak VO₂